|
|
Office Locations:
|
175 Chain Bridge Rd.
McLean, VA 22101
Phone: 703-879-6522
| | |
|
|
|
|
|
Life Sciences & Healthcare
Software & Internet
|
|
|
|
Cobro Ventures is a private investment firm focused on software and biotech. The firm's team has a 20 year track record of building successful businesses as founders, operators, and investors with both private and public exits. Marc A. Cohen, Cobro's CEO, is also the Co-founder, Executive Chairman, and CEO of C4 Therapeutics. Marc is also the Chairman of Frequency Therapeutics (NASDAQ: FREQ). Previously, he was Chairman and Co-founder of Acetylon Pharmaceuticals (sold to Celgene) and OPNET Technologies, Inc. (sold to Riverbed Technology).
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
